CoChat

Creatine in Health and Disease

Open access
Kreider, Richard B., Stout, Jeffery R. · 2021 · Nutrients

The DOI matches its Crossref record; 334 of the 337 references it cites were found in a registry or an index; 66 of the 329 sources its claims cite were checked for support.

Abstract

Although creatine has been mostly studied as an ergogenic aid for exercise, training, and sport, several health and potential therapeutic benefits have been reported. This is because creatine plays a critical role in cellular metabolism, particularly during metabolically stressed states, and limitations in the ability to transport and/or store creatine can impair metabolism. Moreover, increasing availability of creatine in tissue may enhance cellular metabolism and thereby lessen the severity of injury and/or disease conditions, particularly when oxygen availability is compromised. This systematic review assesses the peer-reviewed scientific and medical evidence related to creatine’s role in promoting general health as we age and how creatine supplementation has been used as a nutritional strategy to help individuals recover from injury and/or manage chronic disease. Additionally, it provides reasonable conclusions about the role of creatine on health and disease based on current scientific evidence. Based on this analysis, it can be concluded that creatine supplementation has several health and therapeutic benefits throughout the lifespan.

Overview

CoChat Summary

TL;DR

This systematic review concludes that creatine monohydrate supplementation has health and therapeutic benefits beyond exercise, including support for aging muscle/bone, cognition, glucose management, neuroprotection, rehabilitation, and several clinical conditions. It reports that evidence is promising in many areas but remains limited or equivocal in some populations, especially neurodegenerative disease and pregnancy.

Key findings

  • Creatine supplementation increases muscle creatine/phosphocreatine and generally improves high-intensity exercise performance by 10–20%; the International Society of Sports Nutrition calls it “the most effective ergogenic nutritional supplement currently available to athletes.” Reported health effects include lowering cholesterol/triglycerides, antioxidant effects, enhanced glycemic control, increased strength and muscle mass, minimized bone loss in some studies, and improved cognitive function, particularly in older populations.
  • In older adults, creatine combined with resistance training promotes greater gains in muscle mass and strength. Examples include 5 g/day for 14 weeks, 0.3 g/kg/day for 5 days plus 0.07 g/kg/day for 79 days, and 0.1 g/kg/day for 12 months increasing strength and bone density in postmenopausal women; meta-analyses support greater muscle mass, strength, and functional capacity.
  • In creatine synthesis deficiencies, long-term high-dose creatine (e.g., 0.3–0.8 g/kg/day) increases brain creatine/phosphocreatine and improves or stabilizes clinical symptoms; in 48 children with GAMT deficiency, four treated younger than nine months had normal or almost normal developmental outcomes. Animal neuroprotection studies report 25% reduction in brain damage, 40% decrease in infarction size, and 36% (rats)/50% (mice) reduction in cortical damage after traumatic brain injury.
  • A large trial of 1687 participants taking 9.5 g/day for up to 5 years found no statistically significant improvement in Parkinson’s disease or ALS outcomes, though there was some evidence of attenuated brain atrophy in Huntington’s disease. In type 2 diabetes, 5 g/day for 12 weeks improved glucose tolerance, increased GLUT-4 translocation, and reduced HbA1c; in bipolar depression, 6 g/day for 6 weeks produced 66.7% MADRS remission versus 18.2% with placebo.

Methods

  • The paper describes a systematic review of scientific and medical literature using keyword searches on creatine supplementation for each topic via PubMed.gov; a total of 1322 articles were reviewed, with relevant research highlighted.
  • The review is a narrative synthesis across metabolic role, general health, aging, and therapeutic areas; no meta-analytic pooling, formal inclusion/exclusion criteria, or risk-of-bias assessment is described in the text.

Limitations

  • The paper states that additional research is needed, that not all studies show benefit, that efficacy of long-term high-dose creatine in neurodegenerative diseases is equivocal, and that human pregnancy data are limited so caution should be exercised when recommending use during pregnancy.
  • The text makes evident that many therapeutic conclusions rely on animal models or small/open-label human studies, and that the majority of ergogenic studies have been conducted on men.
  • The review does not report search dates, formal inclusion/exclusion criteria, or quality assessment methods, which limits reproducibility and certainty of the systematic review process.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu13020447

Cites

334 of 334 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

26 Valid · 1 Not valid · 49 Not checked · 48 Own results and interpretations

69 more claims · 15 with their cited sources checked

Create a free account to see all 124 claims and to verify the 263 references still open.

See all claims — free account
  • It may state two separate claims as one. 45
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 334 references

Research works printed but not linked: 2

  1. Mercimek-Mahmutoglu S. Salomons G.S. Creatine Deficiency Syndromes GeneReviews(R) Pagon R.A. Adam M.P. Ardinger H.H. Wallace S.E. Amemiya A. Bean L.J.H. Bird T.D. Ledbetter N. Mefford H.C. Smith R.J.H. University of Washington Seattle, WA, USA 1993 20301745
  2. Rawson E.S. The safety and efficacy of creatine monohydrate supplementation Sport Sci. Exch. 2018 29 1 6

Cited by

See all 227

Metadata

Authors
Kreider, R. B., & Stout, J. R.
Affiliations
  • Texas A&M University (US)
  • Physiology of Work and Exercise Response (POWER) Laboratory, Institute of Exercise Physiology and Rehabilitation Science, School of Kinesiology and Physical Therapy, University of Central Florida, 12494 University Blvd., Orlando, FL 32816, USA
Corresponding author
Kreider, Richard B.
Venue
Nutrients
Publisher
MDPI AG
Published
2021-01-29
Volume
13
Issue
2
Pages
447
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3128849795
Cited by
227
References
337
Citations by year
2026: 48 · 2025: 58 · 2024: 39 · 2023: 39 · 2022: 22 · 2021: 21
FWCI
3.82
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords
creatine, creatine supplementation, ergogenic aids, cellular metabolism, injury recovery, chronic disease management, aging, physical activity, hypoxia
MeSH terms
Aging, Biological Availability, Chronic Disease, Creatine, Humans, Wounds and Injuries, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.